Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002875 · ClinicalTrials.gov registry record · Phase 3
Radiation Therapy Plus Combination Chemotherapy in Treating Children With Medulloblastoma
A Phase 3 study, sponsored by Children's Oncology Group.
- Completed
- Registry status
- Phase 3
- Development phase
- 421
- Enrollment target
NCT00002875 is a Phase 3 study that has completed, run by Children's Oncology Group. The registered enrollment target is 421 participants.
The verdict
NCT00002875, a Phase 3 study, has completed, sponsored by Children's Oncology Group.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 421 participants
- Enrollment target
Study Summary
RATIONALE: Radiation therapy uses high energy x-rays to damage tumor cells. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining radiation therapy with chemotherapy may kill more tumor cells. It is not yet known which chemotherapy regimen is more effective when combined with radiation therapy for treating medulloblastoma. PURPOSE: Randomized phase III trial to compare two combination chemotherapy treatments plus radiation therapy in treating children with newly diagnosed medulloblastoma.
Interventions
- DRUG cisplatin
- DRUG cyclophosphamide
- BIOLOGICAL filgrastim
- DRUG mesna
- DRUG lomustine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 421 participants |
| Start Date | 1996-12 |
| Est. Completion | 2011-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00002875
The ClinicalTrials.gov registry entry for NCT00002875 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 421 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Oncology Group, which has 342 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which cisplatin is the first listed.
NCT00002875 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00002875 about?
NCT00002875 is a clinical study titled "Radiation Therapy Plus Combination Chemotherapy in Treating Children With Medulloblastoma". RATIONALE: Radiation therapy uses high energy x-rays to damage tumor cells. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining radiation therapy with chemotherapy may kill more tumor cells. It is not yet known which chemotherapy reg...
What is the current status of trial NCT00002875?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 421 participants. The study started on 1996-12. Estimated completion is 2011-01.
What interventions are being tested in trial NCT00002875?
The interventions under investigation include: cisplatin (DRUG), cyclophosphamide (DRUG), filgrastim (BIOLOGICAL), mesna (DRUG), lomustine (DRUG).
Who is sponsoring clinical trial NCT00002875?
This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.